R Donald Harvey III PharmD

School/Division:

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 46

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Article

Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

by R. Harvey; X Zhou; U Vaishampayan; D Mahalingam; KY Chung; F Sedarati; C Dong; D Faller; K Venkatakrishnan; N Gupta

2022

Article

Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study

by R. Harvey; Olatunji Alese; RM Connolly; E Laille; U Vaishampayan; V Chung; K Kelly; A Dowlati; P Haluska; LL Siu; S Kummar; R Piekarz; SP Ivy; NM Anders; M Downs; A O'Connor; A Scardina; J Saunders; GL Rosner; MA Carducci; MA Rudek

2020

Article

A non-lethal malarial infection results in reduced drug metabolizing enzyme expression and drug clearance in mice

by Sylvie M. Mimche; Choon-myung Lee; Ken H. Liu; Patrice N. Mimche; R Donald Harvey; Thomas J. Murphy; Beatrice A. Nyagode; Dean P Jones; Tracey J. Lamb; Edward T Morgan

2019